Alaris Equity Partners Announces a $75 Million Bought Deal Offering of 6.25% Convertible Unsecured Senior Debentures and a US$30 Million Investment Into a New Partner
Globenewswire· 2025-12-02 05:26
NOT FOR DISTRIBUTION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAW CALGARY, Alberta, Dec. 01, 2025 (GLOBE NEWSWIRE) -- (all numbers in this release are in Canadian dollars (CAN$) unless otherwise noted) Alaris Equity Partners (TSX:AD.UN) (“Alaris” or the “Trust”) is pleased to announce a $75 million bought deal offering of 6.25% convertible unsecured senior debentures and the completion of a US$30 million investment into a new Partne ...
IREN Announces Proposed Offering of Ordinary Shares to Fund the Repurchase of Convertible Notes
Globenewswire· 2025-12-02 05:22
融资活动概述 - 公司宣布拟向少数购买者进行普通股定向增发[1] - 同时,公司拟进行两笔总额分别为10亿美元、2032年和2033年到期的可转换优先票据的私募发行,承销商可选择额外购买总计最多3亿美元的票据[3] - 花旗、高盛和摩根大通担任此次定向增发的配售代理[5] 资金用途 - 增发及票据发行的净收益将用于:支付与发行新票据相关的 capped call 交易成本、以现金回购部分现有可转换票据、以及用于一般公司用途和营运资本[4] - 若承销商行使超额配售权,额外净收益将用于支付额外的 capped call 交易成本[4] 债务管理 - 公司拟与部分现有票据持有人进行私下协商,以现金回购部分2029年(初始转股价13.64美元)和2030年(初始转股价16.81美元)到期的可转换票据,回购总额预计与定向增发规模相近[2] - 回购完成后,相应票据的本金将减少并注销,不再可转换为普通股[1] 交易结构 - 定向增发的完成不依赖于同时进行的票据发行或回购的完成,票据发行的完成也不依赖于定向增发或回购的完成[5]
Belite Bio Announces Proposed Underwritten Public Offering of American Depositary Shares
Globenewswire· 2025-12-02 05:20
SAN DIEGO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that it has commenced an underwritten public offering of American Depositary Shares (“ADSs”), each representing one of its ordinary shares. All of the securities in the offering are to be sold by Belite Bio. In addition, B ...
Shenandoah Telecommunications Will Participate in 2025 Raymond James TMT and Consumer Conference and 2025 UBS Global Media and Communications Conference
Globenewswire· 2025-12-02 05:20
EDINBURG, Va., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Shenandoah Telecommunications Company (Shentel) (NASDAQ:SHEN) announced that Ed McKay, Chief Executive Officer, will be participating in fiber panel discussions and investor meetings at conferences in New York, December 8 and 9, 2025. The 2025 Raymond James TMT and Consumer Conference will be held at the Lotte New York Palace in New York, NY. Ed McKay will be participating in the We’re Putting the Band(width) back together: The FTTH Wave Continues panel on Mo ...
Ducommun Incorporated Announces Amendment to Credit Facility
Globenewswire· 2025-12-02 05:16
Lowering Cost of Capital and Significantly Upsizing the RevolverCOSTA MESA, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Ducommun Incorporated (NYSE: DCO) (“Ducommun” or the “Company”) today announced that effective November 24, 2025, it entered into an amended credit facility consisting of a $450 million revolving line of credit and a $200 million term loan to replace its existing facility. The new facility will mature in November 2030. Proceeds from the new financing will be used to fully repay the existing ...
Microchip Technology to Present at the UBS Global Technology and AI Conference 2025
Globenewswire· 2025-12-02 05:15
CHANDLER, Ariz., Dec. 01, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:MCHP) – Microchip Technology Incorporated, a leading provider of smart, connected, and secure embedded control solutions, today announced that the Company will present at the UBS Global Technology and AI Conference 2025 on Wednesday, December 3, 2025 at 12:55 p.m. (Mountain Time). Presenting for the Company will be Mr. Steve Sanghi, President and CEO. A live webcast of the presentation will be made available by UBS, and can be accessed on the Microc ...
Protara Therapeutics to Host Conference Call and Webcast to Review New Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in BCG-Naïve NMIBC Patients on Wednesday, December 3, 2025
Globenewswire· 2025-12-02 05:15
NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that it will host a conference call and live webcast at 8:30 am ET on Wednesday, December 3, 2025, to review new data from an interim analysis of the ongoing Phase 2 open-label ADVANCED-2 trial of TARA-002 in BCG-Naïve patients with non-muscle invasive bladder cancer (NMIBC). The data will be feature ...
Navitas Announces 3300V and 2300V UHV Silicon Carbide Product Portfolio, Augmenting Reliability and Performance in Mission-Critical Energy Infrastructure Applications
Globenewswire· 2025-12-02 05:15
New 3300V and 2300V SiC products based on latest GeneSiC™ Trench-Assisted Planar technology and packaging innovations to augment efficiency and lifetime for AI data center, grid and energy infrastructure and industrial electrification including energy storage, renewable, and megawatt-scale fast-charging applications. Navitas Announces 3300V and 2300V UHV Silicon Carbide Product Portfolio, Augmenting Reliability and Performance in Mission-Critical Energy Infrastructure Applications New 3300V and 2300V SiC ...
Cre8 Enterprise Limited Announces Its First Half 2025 Unaudited Financial Results
Globenewswire· 2025-12-02 05:15
Hong Kong, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Cre8 Enterprise Limited (Nasdaq: CRE) (“Cre8” or the “Company”), a Hong Kong-based integrated financial printing service provider, announced its unaudited financial results for the six months ended June 30, 2025 today. Overview: Revenue increased by approximately 1.4% from approximately HK$58.0 million for the six months ended June 30, 2024 to approximately HK$58.8 million (US$7.5 million) for the six months ended June 30, 2025 Net income increased by approximate ...
American Coastal Insurance Corporation Declares Special Cash Dividend of $0.75 Per Share and Announces Executive Fireside Chat to Discuss “The Next Horizon”
Globenewswire· 2025-12-02 05:15
ST. PETERSBURG, Fla., Dec. 01, 2025 (GLOBE NEWSWIRE) -- American Coastal Insurance Corporation (Nasdaq Ticker: ACIC) (“the Company”, “American Coastal” or “ACIC”), the insurance holding company of American Coastal Insurance Company (“AmCoastal”), announced today that its Board of Directors declared a special cash dividend of $0.75 per share of common stock outstanding, payable on January 9, 2026, to shareholders of record on January 2, 2026. Executive Fireside Chat with American Coastal: The Next HorizonAme ...